Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples